BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34429246)

  • 1. Palliative treatment with high-dose-rate endobronchial interventional radiotherapy (Brachytherapy) for lung cancer patients.
    Soror T; Kovács G; Wecker S; Ismail M; Badakhshi H
    Brachytherapy; 2021; 20(6):1269-1275. PubMed ID: 34429246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage treatment with sole high-dose-rate endobronchial interventional radiotherapy (brachytherapy) for isolated endobronchial tumor recurrence in non-small-cell lung cancer patients: a 20-year experience.
    Soror T; Kovács G; Fürschke V; Ismail M; Badakhshi H
    Brachytherapy; 2019; 18(5):727-732. PubMed ID: 31227399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer.
    Chang LF; Horvath J; Peyton W; Ling SS
    Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):589-96. PubMed ID: 7509330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients.
    Ozkok S; Karakoyun-Celik O; Goksel T; Mogulkoc N; Yalman D; Gok G; Bolukbasi Y
    Lung Cancer; 2008 Dec; 62(3):326-33. PubMed ID: 18482780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer.
    Anacak Y; Mogulkoc N; Ozkok S; Goksel T; Haydaroglu A; Bayindir U
    Lung Cancer; 2001 Nov; 34(2):253-9. PubMed ID: 11679184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irriadiated lung cancer.
    Kubaszewska M; Skowronek J; Chicheł A; Kanikowski M
    Neoplasma; 2008; 55(3):239-45. PubMed ID: 18348661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose rate brachytherapy for the local control of endobronchial carcinoma following external irradiation.
    Hernandez P; Gursahaney A; Roman T; Schwartzman K; Donath D; Cosio MG; Levy RD
    Thorax; 1996 Apr; 51(4):354-8. PubMed ID: 8733484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective analysis of high-dose-rate endobronchial brachytherapy in the palliation of obstructive symptoms in lung cancer patients: A single-institution experience.
    Goldberg M; Timotin E; Farrell T; Puksa S; Donde B; Sur R
    Brachytherapy; 2015; 14(5):655-61. PubMed ID: 25983031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: the 10-year M. D. Anderson cancer center experience.
    Kelly JF; Delclos ME; Morice RC; Huaringa A; Allen PK; Komaki R
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):697-702. PubMed ID: 11020566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of high dose rate (HDR) brachytherapy in advanced non-small cell lung cancer].
    Makarewicz R
    Pneumonol Alergol Pol; 2002; 70(5-6):265-77. PubMed ID: 12518625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endobronchial brachytherapy with high-dose-rate remote afterloading for recurrent endobronchial lesions.
    Delclos ME; Komaki R; Morice RC; Allen PK; Davis M; Garden A
    Radiology; 1996 Oct; 201(1):279-82. PubMed ID: 8816560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High-dose endobronchial brachytherapy in malignant tumors of the lung].
    Escobar Sacristán J; de Granda Orive JI; Gutiérrez Jiménez T; Martínez Albiach JM; Fuentes Ramos M; Herrera de la Rosa A
    Arch Bronconeumol; 1997 Jun; 33(6):278-83. PubMed ID: 9289322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reappraisal of the role of endobronchial brachytherapy in the management of lung cancer: ten years' experience at the centre Antoine-Lacassagne].
    Magné N; Porsin B; Marcy PY; Benezery K; Poudenx M; Vallino P; Otto J; Marcié S; Lagrange JL
    Cancer Radiother; 2003 Jun; 7(3):160-5. PubMed ID: 12834770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose rate endoluminal brachytherapy in the treatment of endobronchial lesions - experience of a single institution and literature review.
    Macías-Lozano MJ; Díaz-Díaz V; Sayago-Gil S; García-Polo C; Jaén-Olasolo J
    Support Care Cancer; 2023 Apr; 31(5):260. PubMed ID: 37052737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitive high-dose-rate endobronchial brachytherapy of bronchial stump for lung cancer after surgery.
    Skowronek J; Piorunek T; Kanikowski M; Chicheł A; Bielęda G
    Brachytherapy; 2013; 12(6):560-6. PubMed ID: 23850277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endobronchial radiation therapy for obstructing malignancies: ten years' experience with iridium-192 high-dose radiation brachytherapy afterloading technique in 365 patients.
    Macha HN; Wahlers B; Reichle C; von Zwehl D
    Lung; 1995; 173(5):271-80. PubMed ID: 7564485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer.
    Celebioglu B; Gurkan OU; Erdogan S; Savas I; Köse K; Kurtman C; Gonullu U
    Jpn J Clin Oncol; 2002 Nov; 32(11):443-8. PubMed ID: 12499415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endoluminal HDR brachytherapy in the palliative treatment of patients with the recurrence of a non-small-cell bronchial carcinoma after prior radiotherapy].
    Micke O; Prott FJ; Schäfer U; Wagner W; Pötter R; Willich N
    Strahlenther Onkol; 1995 Oct; 171(10):554-9. PubMed ID: 8571174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endobronchial brachytherapy and external-beam radiotherapy in patients with endobronchial obstruction and extrabronchial extension.
    Gejerman G; Mullokandov EA; Bagiella E; Blaivas A; Beitler JJ
    Brachytherapy; 2002; 1(4):204-10. PubMed ID: 15062168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractionated intraluminal HDR 192Ir brachytherapy as palliative treatment in patients with endobronchial metastases from non-bronchogenic primaries.
    Stranzl H; Gabor S; Mayer R; Prettenhofer U; Wurzinger G; Hackl A
    Strahlenther Onkol; 2002 Aug; 178(8):442-5. PubMed ID: 12240550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.